DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
07 juin 2023 11h17 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, June 07, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A LEADING NATIONAL FIRM, Encourages Fulcrum Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FULC
05 juin 2023 14h23 HE
|
The Rosen Law Firm PA
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.
05 juin 2023 01h45 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm
04 juin 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
31 mai 2023 12h45 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 31, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edgio, Fulcrum, and adidas and Encourages Investors to Contact the Firm
30 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
25 mai 2023 11h40 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm
24 mai 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FULC
23 mai 2023 11h22 HE
|
The Rosen Law Firm PA
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.
22 mai 2023 08h15 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...